Human defensin 5 (HD5) is a 32-residue cysteine-rich host-defense peptide that exhibits three disulfide bonds in the oxidized form (HD5 ox ). It is abundant in small intestinal Paneth cells, which release HD5 into the intestinal lumen and house a labile Zn(II) store of unknown function. Here we consider the redox properties of HD5 and report that the reduced form, HD5 red , is a metal-ion chelator. HD5 has a midpoint potential of -257 mV at pH 7.0. HD5 red utilizes its cysteine residues to coordinate one equivalent of Zn(II) with an apparent K d1 value in the mid-picomolar range. Zn(II) or Cd(II) binding perturbs the oxidative folding pathway of HD5 red to HD5 ox . Whereas HD5 red is highly susceptible to proteolytic degradation, the Zn(II)-bound form displays resistance to hydrolytic breakdown by trypsin and other proteases. The ability of a reduced defensin peptide to coordinate Zn(II) provides a putative mechanism for how these peptides persist in vivo.
Defensins are ribosomally-synthesized, cysteine-rich, host-defense peptides that are biosynthesized by eukaryotes.(1) These peptides are celebrated for antimicrobial activity and other physiological roles that include immunomodulation and chemotatic function. (2) In the oxidized forms, human defensins exhibit regiospecific disulfide linkages that confer a triplestranded β-sheet fold. Until recently, putative physiological roles for the reduced forms of these peptides have been largely overlooked. In vitro antibacterial activity assays with reduced murine cryptdin-4 revealed species-dependent antibacterial activity equal to or greater than that of the oxidized form.(3) Subsequent investigations demonstrated that reduced human β-defensin 1 (HBD-1) is colocalized with thioredoxin in the human colon, (4) and that living intestinal cells are able to reduce extracellular HBD-1 in a thioredoxin-dependent manner. (5) From the perspective of biological coordination chemistry, one striking feature of defensin peptides are the cysteine distributions, which are reminiscent of those observed in zinc-binding peptides such as metallothionein and the transcription factor GAL4. (6, 7) We therefore questioned whether reduced defensins chelate zinc and, if so, whether this property is relevant in vivo.
To address the former notion, we focused on human defensin 5 (HD5, Figure 1 ), which is a 32-aa peptide produced by small intestinal Paneth cells, (8, 9) and in the kidney, urinary, and female reproductive tracts. (10, 11) We selected a Paneth cell defensin to evaluate in this exploratory work because these cells house a labile zinc store of unknown function. (12, 13) Herein we report that (i) HD5 has a midpoint potential in the biological window, (ii) the reduced form of human defensin 5 (HD5 red ) is a mid-picomolar-affinity zinc chelator, and (iii) Zn(II) coordination affords protection of HD5 red against proteolytic degradation by the intestinal protease trypsin and other proteases.
Insert Figure 1 here
The oxidized form of HD5, hereafter HD5 ox , exhibits six cysteine residues that afford the disulfide linkages Cys 3 -Cys 31 , Cys 5 -Cys 20 , and Cys 10 -Cys 30 .(15) Whether HD5 red , the fully reduced species with six thiol residues, exists in vivo is currently unclear. To evaluate this possibility, we determined the midpoint potential of HD5 by incubating anaerobic solutions of HD5 red or HD5 ox in redox buffers with fixed [DTT red ]:[DTT ox ] ratios that spanned the -230 to -290 mV range (75 mM HEPES, pH 7.0). Analytical HPLC of the equilibrium mixtures revealed varying ratios of peaks corresponding to HD5 red and HD5 ox that were dependent on the redox buffer composition ( Supplementary Figure 1) . Nernstian behavior was observed, and a midpoint potential of -257 mV was determined from analysis of the HPLC peak areas (Figure 2a ). This value is well within the range expected for disulfide-containing peptides and proteins Table 1 and references therein), and falls within the redox potential range of the human gut (-150 to -300 mV).(16) Moreover, like HBD-1,(4) HD5 ox is a substrate for mammalian Trx/TrxR. Incubation of HD5 ox with human thioredoxin (Trx), rat liver thioredoxin reductase (TrxR), and NADPH resulted in formation of HD5 red (Figure 2b, Supplementary Figure 2 ). These in vitro assays confirm that the midpoint potential of HD5 falls within the biological window, and support the notion that both the oxidized and reduced species of HD5 may exist under physiological conditions. Figure 2 ), along with peaks corresponding to HD5 red and HD5 ox . As expected, addition of the reducing agent tris (2-carboxyethyl) phosphine to this mixture resulted in disappearance of all the new peaks corresponding to oxidized products (data not shown). These observations indicate that (i) HD5 red coordinates both Zn(II) and Cd(II) in a similar manner, (ii) Zn(II)/Cd(II) binding is dynamic and fluctional, and (iii) metal binding perturbs oxidative folding of HD5 red to HD5 ox . Moreover, the fact that each of the four prominent partially-oxidized peak contains a single disulfide bond suggests that each HD5 monomer employs four Cys residues to coordinate Zn(II) under these conditions. Whether the Zn(II):HD5 species are monomeric or oligomeric requires further investigation. Table 3 ).
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With support for Zn(II) coordination in hand, we evaluated the affinity of HD5 red for Zn(II) by conducting a series of anaerobic titrations where we competed the peptide and a colorimetric or fluorescent Zn(II) sensor of known Zn(II) affinity for the metal ion (75 mM HEPES, pH 7.4).
Zincon, FluoZin-1 (FZ1), MagFura-2 (MF2) and Zinpyr-4 (ZP4) were employed, and these Zn(II) sensors have K d values that span the micromolar (Zincon, FZ1) to mid-picomolar (ZP4) range (Supporting Information). Titration of a 1:1 mixture of HD5 red and Zincon or FZ1 resulted in no optical change of either Zn(II) indicator up to a 1:1 Zn(II)/HD5 red ratio, demonstrating that HD5 red coordinates one Zn(II) ion with higher (i.e. sub-micromolar) affinity than either Zincon or FZ1 (Supplementary Figure 3) . In contrast, competition between HD5 red and both MF2 and ZP4 was observed at 1:2 and 1:10 indicator/HD5 red ratios, respectively (Figure 3d, Supplementary Figure   4 ). The titrations were fit to both 1:1 and 2:1 Zn(II):HD5 red binding models using DynaFit ( Supplementary Figure 4) . Both models afforded apparent K d1 values in the mid-picomolar range, and the 2:1 model provided superior fits (K d1 = 509 ± 54 pM, MF-2; K d1 = 247 ± 23 pM, ZP4; from 2:1 model). The mid-picomolar apparent K d1 value was maintained with addition of 100 mM NaCl to the buffer (Supplementary Figure 4) . The apparent K d2 values obtained from the data fitting spanned the mid-nanomolar range ( Supplementary Figure 4) . These values are lower than the apparent K d2 values predicted from the Zincon/FZ-1 experiments and may reflect the inability of the indicators to report on two K d values that differ by several orders of magnitude. In total, the results from the MF2/ZP4 competition titrations indicate that HD5 red coordinates one zinc ion with mid-picomolar affinity, and suggest a second zinc-binding event with substantially weaker affinity.
Because Zn(II) is a spectroscopically-silent 3d 10 metal ion, the nature of M(II) binding was further investigated by using cobalt(II), a 3d 7 metal ion, as a spectroscopic probe. (17) Well- Table 5 and references therein).
These results support the notion that the HD5 red scaffold affords Co(II) tetrathiolate species, and suggest a distorted T d geometry for Co(II) bound to HD5. Further spectroscopic studies and magnetic characterization are necessary to ascertain whether Co(II)-thiolate clusters, as observed for metallothionein and GAL4, form.
Lastly, we questioned how Zn(II) coordination influences proteolytic stability of the HD5 peptide backbone. Trypsin is responsible for proteolytic processing of the HD5 propeptide in vivo and release of mature HD5 ox .(20) HD5 ox is therefore resistant to degradation by this enzyme (21, 22) as a result of its triple-stranded β-sheet fold whereas linearized HD5 red is susceptible to proteolytic breakdown (Figure 4) . To evaluate whether Zn(II) coordination influences the trypsin susceptibility of HD5 red , we pre-incubated HD5 red with varying equivalents of Zn(II) prior to conducting the trypsin degradation assay, and observed attenuation of proteolysis when >1 equiv of Zn(II) was added ( Figure 4) . Control assays employing HD5-TE, which has all six Cys residues capped by iodoacetamide and cannot form Zn-S bonds, confirmed that Zn(II) addition to the assay mixture did not compromise trypsin activity ( Supplementary Figure 7) . Furthermore, degradation assays employing chymotrypsin and proteinase K revealed that Zn(II) also provides protection of the HD5 backbone from these proteases ( Supplementary Figures 8,9 ).
Insert Figure 4 here
In summary, HD5 has a midpoint potential within the biological window, and the oxidized form is a substrate for mammalian Trx/TrxR. HD5 red provides mid-picomolar-affinity Zn(II) chelation, and the Zn(II) complex exhibits resistance to protease-catalyzed hydrolytic breakdown. Metal-dependent reduction of protease-catalyzed degradation provides a plausible mechanism by which reduced defensins persist and exert functional activity in vivo. Along such lines, how protease-susceptible reduced HBD-1 exists in vivo has been questioned. µg/mL; proteinase K, 1 µg/mL). Aliquots (50 µL) were removed at t = 1, 2, 5, 15, 30, and 60 min and immediately quenched with 5 µL of 6% TFA, vortexed, and stored at -20 o C prior to HPLC analysis. In parallel, assays in which Zn(II) was omitted from the reaction were also performed.
In addition, control assays using HD5-TE, which cannot bind Zn(II), instead of HD5 red were conducted for each protease to confirm that Zn(II) addition did not perturb protease activity.
Supporting Information. Complete experimental methods, DynaFit scripts for dissociation constant determination, Tables S1-S5, and Figures S1-S11. Figure S10 
